2,462
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines

, , , , , , , & show all
Pages 258-263 | Received 17 Apr 2016, Accepted 09 Nov 2016, Published online: 07 Dec 2016

References

  • Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, et al. 2011. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 17:456–520.
  • Bedoya SK, Lam B, Lau K, Larkin J 3rd. 2013. Th17 cells in immunity and autoimmunity. Clin Dev Immunol. 2013:986789
  • Bermejo Benito P, Díaz Lanza AM, Silván Sen AM, De Santos Galindez J, Fernandez Matellano L, Sanz Gómez A, Abad Martínez MJ. 2000. Effects of some iridoids from plant origin on arachidonic acid metabolism in cellular system. Planta Med. 66:324–328.
  • Colobran R, Armengol Mdel P, Faner R, Gärtner M, Tykocinski LO, Lucas A, Ruiz M, Juan M, Kyewski B, Pujol-Borrell R. 2011. Association of an SNP with intrathymic transcription of TSHR and Graves’ disease: a role for defective thymic tolerance. Hum Mol Genet. 20:3415–3423.
  • Cooper DS. 2005. Antithyroid drugs. N Engl J Med. 352:905–917.
  • Daukšienė D, Daukša A, Mickuvienė N. 2013. Independent pretreatment predictors of Graves’ disease outcome. Medicina (Kaunas). 49:427–434.
  • Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. 2002. Human CD4+ CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med. 196:247–253.
  • Esfahanian F, Naimi E, Doroodgar F, Jadali Z. 2013. Th1/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy. Iran J Allergy Asthma Immunol. 12:168–175.
  • Gu F, Ding G, Lou X, Wang X, Mo Z, Zhu W, Zhou J, Mao G. 2016. Incidence of thyroid diseases in Zhejiang Province, China, after 15 years of salt iodization. J Trace Elem Med Biol. 36:57–64.
  • He L, Peng Y, Liu H, Yin W, Chen X, Peng X, Shao J, Liu Y, Liu F. 2014. Th1/Th2 polarization in tonsillar lymphocyte form patients with IgA nephropathy. Ren Fail. 36:407–412.
  • Kennedy RL, Jones TH. 1991. Cytokines in endocrinology: their roles in health and in disease. J Endocrinol. 129:167–178.
  • Latrofa F, Ricci D, Montanelli L, Piaggi P, Mazzi B, Bianchi F, Brozzi F, Santini P, Fiore E, Marinò M, et al. 2014. Thyroglobulin autoantibodies switch to immunoglobulin (Ig)G1 and IgG3 subclasses and preserve their restricted epitope pattern after 131I treatment for Graves’s hyperthyroidism: the activity of autoimmune disease influences subclass distribution but not epitope pattern of autoantibodies. Clin Exp Immunol. 178:438–446.
  • Rodrigues-Díez R, Aroeira LS, Orejudo M, Bajo MA, Heffernan JJ, Rodrigues-Díez RR, Rayego-Mateos S, Ortiz A, Gonzalez-Mateo G, López-Cabrera M, et al. 2014. IL-17A is a novel player in dialysis-induced peritoneal damage. Kidney Int. 86:303–315.
  • Ross DS. 2011. Radioiodine therapy for hyperthyroidism. N Engl J Med. 364:542–550.
  • Stefan M, Wei C, Lombardi A, Li CW, Concepcion ES, Inabnet WB III, Owen R, Zhang W, Tomer Y. 2014. Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity. Proc Natl Acad Sci USA.111:12562–12567.
  • Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, et al. 2006. Effect of iodine intake on thyroid disease in China. N Engl J Med. 354:2783–2793.
  • Wakelkamp IM, Gerdngm N, vail der Meerj W, Prummel MF, Wiersinga WM. 2000. Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol. 121:453–457.
  • Wallaschofski H, Miehle K, Mayer A, Tuschy U, Hentschel B, Paschke R. 2002. Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment. Horm Metab Res. 34:383–388.
  • Weetman AP. 2000. Graves' disease. N Engl J Med. 343:1236–1248.
  • Wei X, Zhang J, Li J, Chen S. 2004. Astrgalus and Polygonum multiflorun’s protective against cyclophoshamide inhibitory effect on thymns. Am J Clin Med. 32:669–680.
  • Xiong SL, Hou DB, Huang N, Li AL. 1958. Preparation and biological activity of saponin from Ophiopogon japonicus. J Dairy Res. 25:315–321.
  • Yang F, Teng W, Shah Z, Guan H, Li Y, Jin Y, Hu F, Shi X, Tong Y, Chen W, et al. 2002. Epidemiological survey on the relationship between different iodine intakes and the prevalence of hyperthyroidism. Eur J Endocrinol. 146:613–618.
  • Yao R, Lin Y, Li Q, Zhou X, Pan X, Bao Y, He M, Zhu B, Guo W, Lin X, et al. 2014. Downregulation of T-bet/GATA-3 ratio induced by IL-11 treatment is responsible for Th1/Th2 balance restoration in human immune thrombocytopenic purpura (ITP). J Thromb. 38:183–189.
  • Yin X, Sachidanandam R, Morshed S, Latif R, Shi R, Davies TF. 2014. mRNA-Seq reveals novel molecular mechanisms and a robust fingerprint in Graves' disease. J Clin Endocrinol Metab. 99:E2076–E2083.
  • Yoshihara A, Noh JY, Watanabe N, Iwaku K, Kobayashi S, Suzuki M, Ohye H, Matsumoto M, Kunii Y, Mukasa K, et al. 2014. Frequency of adverse events of antithyroid drugs administered during pregnancy. J Thyroid Res. 2014:952352.